Skip to search boxSkip to navigationSkip to main content

Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome study

  • Andrew Siderowf(corresponding author)
    ,
  • Danna Jennings
    ,
  • Shirley Eberly
    ,
  • David Oakes
    ,
  • Keith A. Hawkins
    ,
  • Albert Ascherio
*Corresponding author for this work
  • University of Pennsylvania
    ,
  • Institute for Neurodegenerative Disorders
    ,
  • University of Rochester
    ,
  • Yale University
    ,
  • Harvard University
    ,
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

To test the association between impaired olfaction and other prodromal features of PD in the Parkinson At-Risk Syndrome Study. The onset of olfactory dysfunction in PD typically precedes motor features, suggesting that olfactory testing could be used as a screening test. A combined strategy that uses other prodromal nonmotor features, along with olfactory testing, may be more efficient than hyposmia alone for detecting the risk of PD. Individuals with no neurological diagnosis completed a mail survey, including the 40-item University of Pennsylvania Smell Identification Test, and questions on prodromal features of PD. The frequency of reported nonmotor features was compared across individuals with and without hyposmia. A total of 4,999 subjects completed and returned the survey and smell test. Of these, 669 were at or below the 15th percentile based on age and gender, indicating hyposmia. Hyposmics were significantly more likely to endorse nonmotor features, including anxiety and depression, constipation, and rapid eye movement sleep behavior disorder symptoms, and to report changes in motor function. Twenty-six percent of subjects with combinations of four or more nonmotor features were hyposmic, compared to 12% for those reporting three or fewer nonmotor features (P < 0.0001). Hyposmia is associated with other nonmotor features of PD in undiagnosed individuals. Further assessment of hyposmic subjects using more specific markers for degeneration, such as dopamine transporter imaging, will evaluate whether combining hyposmia and other nonmotor features is useful in assessing the risk of future neurodegeneration.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 406-412 (7 pages)

Journal (Volume, Issue Number)

Movement Disorders (Volume 27, Issue 3)

Publication milestones

  • Published - 03/2012

Publication status

Published - 03/2012

ISSN

0885-3185

Publication IDs

  • Scopus: 84858290153
  • PubMed: 22237833

Publication metrics

Metrics

SciVal
citations
131
Scopus
citations
SciVal
FWCI
6.53
SciVal
Author count
53
SciVal
Paper percentile
98
SciVal
Top percentile
5
Fractional count
1
Fractional count
0.02
Fractional count
52
Fractional count
0.98
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
174
Mentions
1
Citation count
169

Funding Details

FunderFunding number
NINDS
K02NS073836